Pharm Access Africa Limited was set up in 2001, to increase access to healthcare to the people of Africa.  In sub-Saharan Africa only a limited number of people can access health care. When Pharm Access Africa Limited was incorporated, per capita spend on health care was close to US$29. Through various initiatives, this number has gradually risen, yet access to affordable health care still remains a problem.

Kenya is classified as a Lower Middle- Income Country (LMIC) with a population of 44.2 million and a GNI per capita of US$1620 in 2018 and 36.1% of the population living under the poverty line in 2015.

GOK Health Expenditure as a proportion of Total Government Expenditure increased from 6.1% in 2012/13 to 7.6% in 2016/17 and 9.2% in FY2018/19. County Governments increased the proportion of their total budgets allocated to health from 13.9% in FY 2013/14 to 27.2% in FY 2018/19.However out-of-pocket spending still remains a large source of health financing accounting for 32.8% of total health spending in 2015/16. While national contributions to HIV/AIDS, increased from 19.8% in FY2012/13 to 25.5% in FY2015/16 and 28% in FY2016/17, donors remain the predominant source of HIV financing, contributing 63% of HIV expenditures in FY 2015/16. In FY 2016/17 the national HIV response funding gap was reported as US$173 million.

PAAL provides technical assistance to a number of public and private sector programs, linking these initiatives to major donor organizations in order to provide care, support and sustainability.

We facilitate and strengthen mechanisms for all parties involved, working collaboratively at national and international levels in the area of reproductive health, HIV/AIDS and non communicable diseases. Over the years, partnerships have spurned with the national AIDS control programs, community groups,  civil societies, faith based organizations, development partners and international donors including among others, the World Bank and The Global Fund for AIDS, TB and malaria.

PROJECTS

WHAT WE DO

SHANGRING: Male Circumcision Device

Circumcision reduces risk of transmission of HIV by over 65 percent. It is associated with reduced risk of HPV (32-35%), HSV-2 (25-34%), STIs, and prevention of genital cancers, including cervical and penile1.

Learn More

LEVOPLANT/ZARIN

Levoplant/Zarin®, also known as Sino-implant (II), is a subcutaneous contraceptive implant manufactured in China by Shanghai Dahua Pharmaceutical Company Limited.

Learn More

HIV AT THE WORKPLACE

Pharm Access Africa Limited (PAAL) was selected by Aureos Capital to start and implement an HIV/AIDS workplace program with a group of companies in East Africa.

Learn More

GOLD STAR NETWORK

The Gold Star Network is a social franchise program established in 2006 to promote comprehensive & quality HIV care amongst a network of private health providers in Kenya..

Learn More

AAART

The World Health Organization estimates that 33.4 million people worldwide are HIV positive. Approximately 22.4 million people living in sub-Saharan Africa are HIV positive.

Learn More

SANI-HANDS Touch Free Automatic Dispenser

Centers for Disease Control and Prevention (CDC) indicates that hand disinfection is key in the prevention of nosocomial infections since more than 80% of all infectious diseases are spread by hand contact.

Learn More

United Nations Population Fund Kenya (UNFPA Kenya)

United Nations Population Fund Kenya (UNFPA Kenya)...

Learn More

Tupange

TUPANGE was a Bill and Melinda Gates Foundation (BMGF) funded and JHPIEGO, an international NGO affiliated with Johns Hopkins University lead project with a consortium of partners including National Council of...

Learn More